US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jul 19, 2016 (10 years ago)

Venlafaxine HCL ER Capsule USP, 75mg, packaged in a) 30-count bottles (NDC 68382-035-06)…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications: out of specification dissolution results in retained samples

What was recalled

Venlafaxine HCL ER Capsule USP, 75mg, packaged in a) 30-count bottles (NDC 68382-035-06), b) 90-count bottles (NDC 68382-035-16), and c) 1000-count bottles, (NDC 68382-035-10), Rx only, Manufactured by : Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534.

Recalling firm
Zydus Pharmaceuticals USA Inc
NDC code
68382-035-06
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1461-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Venlafaxine recalls

See all